All News
EULAR 2022 – Day 2 Report
A full day at EULAR with oral and poster presentations of abstracts in the morning and a plethora of scientific (review) sessions in the afternoon. The latter covering topics like sarcoidosis, Still’s disease, fibromyalgia, back pain, sarcopenia, APS, IgG4 and imaging in vasculitis.
Read Article
Babies! Safety and Outcomes Data on Pregnancies
EULAR Congress 2022 highlighted several posters on pregnancy, an important subject as most rheumatic diseases afflicts women during their childbearing years.
Read Article
Polymyalgia rheumatica immunological puzzle further illustrated
Infiltrating macrophages expressing IL-6 and GM-CSF may drive the subacromial bursitis often seen in polymyalgia rheumatica, according to new research (abstract OP0015) prese
Read Article
In fact, in some select situations we can get by very well without seeing our patient at all?
#EULAR2022 @RheumNow https://t.co/4qcaj2KR9B
David Liew drdavidliew ( View Tweet)
So maybe telemedicine can bring us the efficiency that we badly need. In rheumatology, we're drowning in demand - is telemedicine part of the solution?
#EULAR2022 @RheumNow https://t.co/kHBIYRIvBA
David Liew drdavidliew ( View Tweet)
#EULAR2022 Debate happening now:
📺⚕️Telemedicine: Salvation or necessary evil?
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
#EULAR2022
Rebuttal!
💻⚕️
Telemedicine improves patient-doctor relationship
Supplements F2F visits, making them more efficient
Patients are communicating, texting all the time
Can AI help improve early pt communication?
@ChristianDejaco
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
Hilarious debate #EULAR2022 between Christian Dejaco and Robert Landewe on whether telemedicine is the future of rheumatology. In amongst the trash talking, here are some highlights @RheumNow
David Liew drdavidliew ( View Tweet)
#EULAR2022 Telemedicine: PROs
💻Triage, reduce wait time, direct other specialty referral
💻High agreement w F2F evaluation (79-97%)
💻Saves resources, react quickly to minor flare
💻Better adherence
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
📲The great debate on Telemedicine 💻
R. Landewe warns us against "check box medicine" and its consequences on AxSpA overdiagnosis.
@RheumNow #EULAR2022 https://t.co/Xwg0aAdHwE
Aurelie Najm AurelieRheumo ( View Tweet)
#EULAR2022 @ChristianDejaco: Do we need see our patient at all?
Provocative statement asking if some disease states can be evaluated, diagnosed, educated and monitored digitally.
"It's already out there!" "Should we leave it to the market" or should rheum take a lead?
@RheumNow https://t.co/iMrlKZgtbg
Eric Dein ericdeinmd ( View Tweet)
Casado et al. Efficacy of US guided needle fragmentation or lavage for calcific tendonitis refractory subacromial injection. Mean VAS decreased from 7.6±1.5 to 4.5±3.8 at month 4, 82.9% radiologic improvement. No control group! @RheumNow #EULAR2022 OP0289 https://t.co/KarkB7XL8u
Links:
Richard Conway RichardPAConway ( View Tweet)
#EULAR2022 POS0276
Xray & US for CPPD:
US: sensitivity in all sites
Xray: highly specific, low sensitivity
Combo: Best for patients with Negative Xray or Inconclusive US (only one positive site)
@Rheumnow @MymaAlbaydaMD @USSONAR_Rh
Eric Dein ericdeinmd ( View Tweet)
PMR/GCA patients: should you be worried about how well your COVID vaccine worked?
Actually, post-two vaccines, pretty good Ab (&cellular) response, esp if not on MTX/PNL>10
Glad to see our PMR/GCA pts protected
@VasculitisUMCG @SleenYannick @ElisabethBrouw3 #EULAR2022 @RheumNow https://t.co/9vy0W4ojOF
David Liew drdavidliew ( View Tweet)
There's nothing like a good physical examination
Temporal artery exam & ultrasound vs temporal artery biopsy
n=97 consecutive ?GCA pts from Carlo Salvarini's group
Very decent PPV
Those TA exam findings can be hard to find, but they're gold dust.
POS0820 #EULAR2022 @RheumNow https://t.co/X9TzIqQBaB
David Liew drdavidliew ( View Tweet)
The third SARS-CoV-2 vaccine in IMID (RA, SpA, PsA, UC, CD) patients on immunosuppression improves the serologic response follow the first two vaccine doses and allowed them to close the gap compared to the two-dose vaccinated controls #EULAR2022 @RheumNow OP0192 Jyssum et al
Dr. Antoni Chan synovialjoints ( View Tweet)
Are wearable devices useful in assessing physical activity in rheumatic diseases?
Meta-analysis showed pts with rheumatic diseases reached recommended threshold for moderate to vigorous physical activity but not daily steps.
@RheumNow #EULAR2022 POST#POS0163
Robert B Chao, MD doctorRBC ( View Tweet)
Visual symptoms in GCA: should we take it on face value?
@cmukhtyar group tertiary rheum/ophthal
n=350 consecutive GCA pts diagnosed (bx/PET)
visual symptoms 29%
ocular signs 13%
Not all symptoms = signs
No doubt not all symptoms of same concern
POS0810 #EULAR2022 @RheumNow https://t.co/TYHylpBhkN
David Liew drdavidliew ( View Tweet)
Can genetics solve all the world's problems with predicting response to therapy in rheumatology?
No - but maybe it can be a part of the solution?
Multi-domain apporaches (including good clinical data) needed to really have cut-through
@karolinskainst OP0267 #EULAR2022 @RheumNow https://t.co/wISPUB6m64
David Liew drdavidliew ( View Tweet)
Watch: EULAR 2022 - Day 1 Faculty Recap Pane
Drs. Jack Cush, Eric Dein and Kathryn Dao discuss highlights from day 1 at #EULAR2022 - Guidelines, Lupus, and more.
https://t.co/OBLt7dOMa3 https://t.co/lHmEOIFIGa
Links:
Dr. John Cush RheumNow ( View Tweet)
